Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 11/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.41 |
| ▸ | TNK1 | Q13470 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | SIRT6 | Q8N6T7 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5363025 | 0.77 | SIRT6 (0.56) | TDP1MAPTALDH1A1LMNASIRT6 | |
| SCHEMBL23538613 | 0.75 | ALDH1A1 (0.54) | ATMTDP1MAPTALDH1A1CYP1A2 | |
| SCHEMBL16993799 | 0.75 | MAPT (0.69) | MAPTALDH1A1CYP1A2CYP2C19L3MBTL1 | |
| SCHEMBL30416098 | 0.75 | HPGD (0.68) | MAPTALDH1A1CYP1A2CYP2C19L3MBTL1 | |
| Hydrochloric Acid SCHEMBL10360257 | 0.74 | MAPT (0.68) | MAPTALDH1A1CYP1A2CYP2C19L3MBTL1 | |
| SCHEMBL5371824 | 0.74 | ALDH1A1 (0.41) | TDP1MAPTALDH1A1CYP1A2RECQL | |
| SCHEMBL5356318 | 0.73 | ALDH1A1 (0.62) | MAPTALDH1A1PARP1TNK2TNK1 | |
| SCHEMBL2589998 | 0.72 | MAPT (0.69) | TDP1MAPTALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL24267633 | 0.72 | SIRT6 (0.69) | MAPTALDH1A1CYP1A2CYP2C19L3MBTL1 | |
| SCHEMBL31327888 | 0.72 | ATM (0.45) | ATMTDP1MAPTALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7183301-B2 | Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them | DR. REDDY'S RESEARCH FOUNDATION (IN) | 2007-02-27 | — | — | US | disclosed |
| US-7030148-B2 | Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them | DR. REDDY'S RESEARCH FOUNDATION (IN) | 2006-04-18 | — | — | US | disclosed |
| US-20040059120-A1 | Novel heterocyclic compounds having antibacterial activity: Process for their preparation and pharmaceutical compositions containing them | DR. REDDY'S LABORATORIES INC. | 2004-03-25 | — | — | US | disclosed |
| EP-1345913-A2 | HETEROCYCLIC COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Dr. Reddy's Laboratories Ltd. (IN) | 2003-09-24 | — | — | EP | disclosed |
| WO-2002051819-A9 | HETEROCYCLIC COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | REDDYS LAB LTD DR (IN) | 2003-08-07 | — | — | WO | disclosed |
| US-20030065175-A1 | Novel heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them | DR. REDDY'S RESEARCH FOUNDATION | 2003-04-03 | — | — | US | disclosed |
| WO-2002051819-A2 | HETEROCYCLIC COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DR. REDDY'S LABORATORIES LTD. (IN) | 2002-07-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065175-A1 | Novel heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them | MRPL21, Q6ZSR9, ZYX | ATM 4651/4885TDP1 1945/4885MAPT 503/4885 |
| US-20040059120-A1 | Novel heterocyclic compounds having antibacterial activity: Process for their preparation and pharmaceutical compositions containing them | MRPL21, Q6ZSR9, ZYX | ATM 4596/4885TDP1 2290/4885MAPT 604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.